Journals / Haseki Tıp Bülteni / 2019 / Cilt: 57 - Sayı: 1

Is Morbidity High in Completion Thyroidectomy?

Tamamlayıcı Tiroidektomide Morbidite Yüksek midir?

Pages
69–74
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, in experienced hands, the rate of permanent complications does not change.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: We aimed to compare primary total thyroidectomy and completion thyroidectomy in terms of postoperative morbidity.
📊
Key Findings & Data:Results: There were no statistically significant difference in age, sex (p=0.998), hormonal status (p=0.287), presence of nodule (p=0.287), number of lobes removed (p=0.695), multicentricity (p=0.081) in regard to complications between the two groups.
💡
Conclusion & Impact:However, in experienced hands, the rate of permanent complications does not change.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: We aimed to compare primary total thyroidectomy and completion thyroidectomy in terms of postoperative morbidity. Methods: The morbidity of primary thyroidectomy operations and completion thyroidectomy operations performed in the general surgery clinic at Haseki Research and Training Hospital Hospital was retrospectively evaluated. Consecutive patients, in whom neuromonitoring was not done according to the surgeon’s choice, were enrolled for primary thyroidectomy and completion thyroidectomy groups. Results: There were no statistically significant difference in age, sex (p=0.998), hormonal status (p=0.287), presence of nodule (p=0.287), number of lobes removed (p=0.695), multicentricity (p=0.081) in regard to complications between the two groups. It was seen that the risk ratio (the odds ratio) was 11.9 times higher in patients in whom appropriate time was not waited for the second operation. When all patients were evaluated, the distribution of complication was found to be significantly higher in group 2 than in group 1 (p=0.003). The probability of developing complications in group 2 was 10.6 fold (odds ratio) higher than in group 1. Neither nerve nor parathyroid damage was permanent. Conclusion: Although technological developments and preoperative diagnostic methods reduce the need for completion thyroidectomy nowadays, the probability of complication is higher than that in patients who initially underwent total thyroidectomy. However, in experienced hands, the rate of permanent complications does not change.

Özet

Amaç: Primer olarak yapılan total tiroidektomi ile tamamlayıcı tiroidektomiyi ameliyat sonrası morbidite açısından karşılaştırmayı amaçladık. Yöntemler: Haseki Eğitim ve Araştırma Hastanesi Genel Cerrahi Kliniği’nde yapılan tamamlayıcı tiroidektomi ameliyatları ile primer total tiroidektomi ameliyatlarındaki morbidite retrospektif olarak incelendi. Cerrah tercihine göre nöromonitorizasyonun kullanılmadığı, ardışık olarak ameliyat edilen hastalar değerlendirilmiştir. Bulgular: İncelenen parametrelerden hiçbirinde yaş (p=0,207), cinsiyet (p=0,998), hormon durumu (p=0,287), nodül mevcudiyeti (p=0,287), çıkarılan lob sayısı (p=0,695), multisentrisite (p=0,081) komplikasyon oluşumu ile çalışıldığında hiçbirinde istatistiksel anlam farkı saptanmadı. Göreli orantı yönünden (odds ratio) 11,9 kat daha fazla komplikasyon riskinin ikinci ameliyat için uygun sürenin dikkate alınmadığı hastalarda oluştuğu görüldü. Tüm hastalar ele alındığında komplikasyon varlığının dağılımı tamamlayıcı tiroidektomi yapılan grupta (grup 2), ilk baştan total tiroidektomi yapılan gruptan (grup 1) anlamlı derecede yüksek bulunmuştur (p=0,003). Grup 2’de komplikasyon gelişme olasılığı grup 1’den 10,6 kat (odds ratio) fazla gözlenmiştir. Sinir ve paratiroid hasarlarının hiçbiri kalıcı olmamıştır. Sonuç: Günümüzde teknolojik gelişmeler ve ameliyat öncesi tanı yöntemleri tamamlayıcı tiroidektomi gereksinimini azaltsada, yapıldığında komplikasyon olasılığı baştan total tiroidektomi yapılan hastalardan daha fazladır. Ancak deneyimli ellerde kalıcı komplikasyon oranı değişmemektedir.

🔖

Cite This Article

GÜR, H. Ü., MADENCİ, C., ÇITLAK, G., YÜKSEL, S., FERLENGEZ, E., ERÖZGEN, F. (2019). Is Morbidity High in Completion Thyroidectomy?. Haseki Tıp Bülteni, Cilt: 57 - Sayı: 1, 69–74. https://ajindex.com/articles/165891

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Li YJ, Wang YZ, Yi ZB, Chen LL, Zhou XD. Comparison of Completion Thyroidectomy and Primary Total Surgery for Differentiated Thyroid Cancer: A Meta-Analysis. Oncol Res Treat 2015;38:528-31.
  2. Gulcelik MA, Kuru B, Dincer H, et al. Complications of completion versus total thyroidectomy. Asian Pac J Cancer Prev 2012;13:5225-8.
  3. Corso C, Gomez X, Sanabria A, Vega V, Dominguez LC, Osorio C. Total thyroidectomy versus hemithyroidectomy for patients with follicular neoplasm. A cost-utility analysis. Int J Surg 2014;12:837-42.
  4. Cirocchi R, Trastulli S, Randolph J, et al. Total or near-total thyroidectomy versus subtotal thyroidectomy for multinodular non-toxic goitre in adults. Cochrane Database Syst Rev 2015;7:CD010370. Machens A, Hinze R, Lautenschlager C, Thomusch O, Dralle H. Prophylactic completion thyroidectomy for differentiated thyroid carcinoma: prediction of extrathyroidal soft tissue infiltrates. Thyroid 2001;11:381-4.
  5. Pacini F, Elisei R, Capezzone M, et al. Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients. Thyroid 2001;11:877-81.
  6. Agarwal A, Mishra SK. Completion total thyroidectomy in the management of differentiated thyroid carcinoma. Aust N Z J Surg 1996;66:358-9.
  7. Erbil Y, Bozbora A, Ademoğlu E, Salmaslıoğlu A, Özarmağan S. J Otolaryngeol Head Neck Surg 2008;37:56-64.
  8. Walgenbach S, Junginger T. Is the timing of completion thyroidectomy for differentiated thyroid carcinoma prognostic significant? Zentralbl Chir 2002;127:435-8.
  9. El-Zohairy M, Zaher A. Re-operation for the treatment of well differentiated thyroid cancer: Necessity, safety and impaction on further management. J Egypt Natl Canc Inst 2004;1:130-6.
  10. Pasieka JL, Thompson NW, McLeod MK, et al. The incidence of bilateral welldifferentiated thyroid cancer found at completion thyroidectomy. World J Surg 1992;16:711-3.
  11. De Groot LJ, Kaplan EL. Second operations for “completion” of thyroidectomy in treatment of differentiated thyroid cancer. Surgery 1991;110:936-7.
  12. Untch BR, Palmer FL, Ganly I, et al. Oncologic outcomes after completion thyroidectomy for patients with well-differentiated thyroid carcinoma. Ann Surg Oncol 2014;21:1374-8.
  13. Kısaoğlu A, Özoğul B, Akçay MN, et al. Completion thyroidectomy in differentiated thyroid cancer: When to perform? Ulus Cerrahi Derg 2014;30:18-21.
  14. Chao TC, Jeng LB, Lin JD, Chen MF. Completion thyroidectomy for differentiated thyroid carcinoma. Otolaryngol Head Neck Surg 1998;118:896-9. Wax M